A Review on the Development of a Standardized Synbiotic Polyherbal Functional Food for Metabolic and Hormonal Health in Women with PCOS

Authors

Deepadharshini M.

Department of Nutrition and Dietetics, Vellalar College for Women (Autonomous), Thindal, Erode – 638102, Tamil Nadu (India)

Dr. P. Vidya

Department of Nutrition and Dietetics, Vellalar College for Women (Autonomous), Thindal, Erode – 638102, Tamil Nadu (India)

Article Information

DOI: 10.51244/IJRSI.2026.1315PH00197

Subject Category: Health Science

Volume/Issue: 13/15 | Page No: 3861-3864

Publication Timeline

Submitted: 2026-10-21

Accepted: 2026-10-26

Published: 2026-11-04

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder characterized by reproductive dysfunction, hyperandrogenism, insulin resistance and menstrual irregularities. Growing interest in food-based interventions has encouraged research into functional foods containing probiotics, prebiotics and plant-derived bioactive compounds. Synbiotics combine live microorganisms with substrates that support beneficial microbial activity, potentially influencing glucose regulation, lipid metabolism and inflammatory pathways. Polyherbal ingredients such as cinnamon, fenugreek, turmeric, ginger, shatavari and ashwagandha have also been investigated for their potential metabolic, antioxidant and reproductive effects. Nutrient-rich ingredients, including garden cress, moringa, amla and flaxseed, may further contribute dietary fibre, minerals, vitamins and other bioactive compounds. This review summarizes the evidence concerning PCOS, synbiotic functional foods and selected herbal ingredients, highlighting their potential incorporation into a standardized functional food. Further research is required to establish formulation stability, probiotic viability, safety, sensory acceptability and clinical effectiveness.

Keywords

PCOS, synbiotic functional food, polyherbal formulation, probiotics, metabolic health, hormonal health.

Downloads

References

1. Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Hum Reprod. 2023;38(9):1655-1679. doi:10.1093/humrep/dead156 [Google Scholar] [Crossref]

2. World Health Organization. Polycystic ovary syndrome. Geneva: WHO; 2026. Available at: https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome [Google Scholar] [Crossref]

3. Senthilkumar H and Arumugam M (2025), Gut microbiota: a hidden player in polycystic ovary syndrome. Journal of Translational Medicine, April 2025, 23:443, DOI:10.1186/s12967-025-06315-7, [Google Scholar] [Crossref]

4. Angoorani P, Ejtahed HS, Ettehad Marvasti F, Taghavi M, Mohammadpour Ahranjani B, Hasani-Ranjbar S and Larijani B (2023), The effects of probiotics, prebiotics, and synbiotics on polycystic ovarian syndrome: an overview of systematic reviews, Frontiers in Medicine. 2023;10:1141355. doi:10.3389/fmed.2023.1141355. [Google Scholar] [Crossref]

5. Cozzolino M, Vitagliano A, Pellegrini L, Chiurazzi M, Andraiasani A, Ambrosoni G and Garrido N(2020), Therapy with probiotics and synbiotics for polycystic ovary syndrome: a systematic review and meta-analysis. European Journal of Nutrition. 2020;59(7):2841–2856. doi:10.1007/s00394-020-02233-0. [Google Scholar] [Crossref]

6. Talebi S, Zeraattalab-Motlagh S, Jalilpiran Y, Payandeh N, Ansari S, Mohammadi H, Djafarian K, Ranjbar M, Sadeghi S, Taghizadeh M and Shab-Bidar S (2023), The effects of pro-, pre-, and synbiotics supplementation on polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials. Frontiers in Nutrition. 2023;10:1178842. doi:10.3389/fnut.2023.1178842. [Google Scholar] [Crossref]

7. Swanson KS, Gibson GR, Hutkins R, Reimer RA, Reid G, Verbeke K , Scott KP , Holscher HD, Holscher HD, Delzenne NM and Sanders ME(2020), The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics. Nature Reviews Gastroenterology & Hepatology. 2020;17(11):687–701. doi:10.1038/s41575-020-0344-2. [Google Scholar] [Crossref]

8. Heshmati J, Sepidarkish M, Morvaridzadeh M, Farsi F, Tripathi N, Razavi M an Rezarinejad M (2021),The effect of cinnamon supplementation on glycemic control in women with polycystic ovary syndrome: a systematic review and meta-analysis. Journal of Food Biochemistry. 2021;45(1). doi:10.1111/jfbc.13543. [Google Scholar] [Crossref]

9. Gong J, Fang K, Dong H, Wang D, Hu M and Lu F(2016), Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: a meta-analysis. Journal of Ethnopharmacology. 2016;194:260–268. [Google Scholar] [Crossref]

10. Kannappan S and Anuradha CV (2009), Insulin sensitizing actions of fenugreek seed polyphenols, quercetin and metformin in a rat model. Indian Journal of Medical Research. 2009;129:401–8. [Google Scholar] [Crossref]

11. Jaipuriar AS, Gupta SK and Lamgora G (2018), Clinical evaluation of standardized fenugreek seed extract as furostanolic saponins (Furocyst) in polycystic ovary syndrome patients. Journal of Gynecology and Reproductive Medicine. 2018;2:1–5, DOI: 10.33140/JGRM. [Google Scholar] [Crossref]

12. Kamal DAM, Salamt N, Yusuf ANM, Kashim M and Mokhtar MH (2021), Potential health benefits of curcumin on female reproductive disorders: a review. Nutrients. 2021;13(9):3126. doi:10.3390/nu13093126. [Google Scholar] [Crossref]

13. Sohaei S, Amani R, Tarrahi MJ and Ghasemi-Tehrani H (2019),The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial. Complementary Therapies in Medicine. 2019;47:102201. doi:10.1016/j.ctim.2019.102201. [Google Scholar] [Crossref]

14. Jamilian M, Foroozanfard F, Kavossian E, Aghadavod E, Shafabakhsh R, Hoseini A and Asemi Z (2020), Effects of curcumin on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clinical Nutrition ESPEN. 2020;36:128–133. doi:10.1016/j.clnesp.2020.01.005. [Google Scholar] [Crossref]

15. Atashpour S, Kargar Jahromi H, Kargar Jahromi Z and Maleknasab M (2017), Comparison of the effects of ginger extract with clomiphene citrate on sex hormones in rats with polycystic ovarian syndrome. International Journal of Reproductive BioMedicine. 2017;15:561–568. [Google Scholar] [Crossref]

16. Babaei O (2020), The effect of 12-week Pilates training and ginger supplementation on polycystic ovary syndrome in women. Studies in Medical Sciences. 2020;31:146–157. Verify the bibliographic details and study design before citing. [Google Scholar] [Crossref]

17. Vishnuvardhan C, Pazhanivel N, Rao GVS and Parthiban M (2022), Alleviative effect of aqueous extract of Asparagus racemosus on the haemato-biochemical parameters of experimentally induced polycystic ovarian syndrome in Wistar rats. Indian Journal of Veterinary and Animal Sciences Research. 2023;51:39–45. doi:10.56093/ijvasr.v51i6.135651. [Google Scholar] [Crossref]

18. Ghosh A, Kar TK, Sil S, Barman A, Sali S (2025), Therapeutic potential of Asparagus racemosus and Vitex negundo against polycystic ovary syndrome in Wistar rats: exploring an oxidative stress independent mechanism. Macedonian Veterinary Review. 2025;48(2):217–228. doi:10.2478/macvetrev-2025-0026. [Google Scholar] [Crossref]

19. Budhiraja RD, Krishnan P and Sudhir S ( [Google Scholar] [Crossref]

20. 2000), Review of biological activity of withanolides. Journal of Scientific and Industrial Research. 1987;46:488–491. [Google Scholar] [Crossref]

21. Ouzir M, El Bairi K and Amzazi S (2016), Toxicological properties of fenugreek (Trigonella foenum-graecum), Food and Chemical Toxicology. 2016;96:145–154, doi: 10.1016/j.fct.2016.08.003. Epub 2016 Aug 4. [Google Scholar] [Crossref]

Metrics

Views & Downloads

Similar Articles